Franklin Covey Co
FC NYSE Services-Management Services Financials FY2016βFY2025
What Franklin Covey Co does
No business description yet.
- Legal name
- FRANKLIN COVEY CO
- Fiscal year ends
- August 31, 2025
- Latest annual report
- 10-K Β· Nov 12, 2025
- Accession Β· CIK
- 0000886206-25-000085
0000886206
Revenue and margins
Franklin Covey Co had $267M of revenue in fiscal 2025, down 7.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β7.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $20.7M in fiscal 2025, 7.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Franklin Covey Co returned $26.4M to shareholders in fiscal 2025, 127% of free cash flow. The diluted share count fell 3.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Franklin Covey Co can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $47.4M | $60.5M | $38.2M | $48.7M | $31.7M |
| Debt incl. finance leases | $31.5M | β | β | β | β |
| Net debt / EBITDA | β1.1x | β | β | β | β |
| Debt / equity | 0.2x | β | β | β | β |
| Interest coverage | 3.9x | 14.1x | 16.7x | 29.5x | 10.1x |
| Current ratio | 1.0x | 1.0x | 1.0x | 1.0x | 0.8x |
| Quick ratio | 1.0x | 1.0x | 0.9x | 1.0x | 0.8x |
| Total assets | $250M | $259M | $246M | $262M | $243M |
| Total liabilities | $170M | $176M | $167M | $178M | $176M |
| Shareholders' equity | $79.9M | $82.8M | $78.7M | $83.1M | $66.9M |
| Net debt (β = net cash) | β$15.9M | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 5 / 9 | 5 / 8 | 4 / 8 | 6 / 8 | 6 / 8 | 6 / 8 | 7 / 8 | 5 / 8 |
| Accruals ratio | β13.4% | β12.2% | β10.7% | β14.3% | β17.2% | β14.3% | β13.3% | β7.1% | β14.5% | β10.3% |
| Altman Z'' | 4.04 | 1.85 | 1.66 | 2.00 | 1.29 | 1.55 | 2.19 | 2.36 | 2.82 | 1.50 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $200M | $185M | $210M | $225M | $198M | $224M | $263M | $281M | $287M | $267M |
| Gross profit | $135M | $123M | $148M | $159M | $145M | $173M | $202M | $213M | $221M | $204M |
| Operating income | $13.8M | β$8.9M | β$3.4M | $2.7M | $3.1M | $8.1M | $23.7M | $26.4M | $33.0M | $5.7M |
| Interest expense | $2.3M | $2.4M | $2.7M | $2.4M | $2.3M | $2.1M | $1.7M | $1.6M | $1.1M | $0.6M |
| Pretax income | $11.9M | β$10.9M | β$5.5M | $0.6M | $0.8M | $6.1M | $22.1M | $25.9M | $33.0M | $6.1M |
| Income tax | $4.9M | β$3.7M | $0.4M | $1.6M | $10.2M | β$7.5M | $3.6M | $8.1M | $9.6M | $3.0M |
| Net income | $7.0M | β$7.2M | β$5.9M | β$1.0M | β$9.4M | $13.6M | $18.4M | $17.8M | $23.4M | $3.1M |
| Diluted EPS | $0.47 | β$0.52 | β$0.43 | β$0.07 | β$0.68 | $0.96 | $1.27 | $1.24 | $1.74 | $0.24 |
| Diluted shares | 0.02B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $32.7M | $17.4M | $16.9M | $30.5M | $27.6M | $46.2M | $52.3M | $35.7M | $60.3M | $29.0M |
| Capital expenditure | $4.0M | $7.2M | $6.5M | $4.2M | $4.2M | $1.6M | $3.2M | $4.5M | $3.7M | $8.3M |
| Free cash flow | $28.7M | $10.2M | $10.3M | $26.3M | $23.4M | $44.6M | $49.1M | $31.2M | $56.6M | $20.7M |
| Depreciation and amortization | $6.9M | $7.4M | $10.5M | $11.4M | $11.3M | $6.2M | $4.9M | $4.3M | $3.9M | $4.1M |
| Stock-based compensation | $3.1M | $3.7M | $2.8M | $4.8M | β$0.6M | $8.6M | $8.3M | $12.5M | $10.1M | $5.8M |
| Acquisitions | β | $7.3M | $1.1M | $0.0M | β | $10.2M | β | β | β | β |
| Share buybacks | $43.6M | $5.4M | $2.0M | $0.0M | $14.0M | $3.0M | $23.9M | $35.6M | $30.7M | $26.4M |
| Dividends and buybacks | $43.6M | $5.4M | $2.0M | $0.0M | $14.0M | $3.0M | $23.9M | $35.6M | $30.7M | $26.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $10.5M | $8.9M | $10.2M | $27.7M | $27.1M | $47.4M | $60.5M | $38.2M | $48.7M | $31.7M |
| Total debt | $1.7M | $1.9M | $2.1M | β | β | $18.8M | β | β | β | β |
| Finance lease liabilities | β | β | β | β | β | $12.7M | $9.8M | $6.7M | $3.1M | β |
| Current assets | $89.7M | $91.8M | $100M | $119M | $102M | $137M | $156M | $145M | $160M | $129M |
| Current liabilities | $54.1M | $80.6M | $94.8M | $104M | $103M | $137M | $154M | $152M | $162M | $157M |
| Inventory | $5.0M | $3.2M | $3.2M | $3.5M | $3.0M | $2.5M | $3.5M | $4.2M | $4.0M | $5.2M |
| Property and equipment, net | $16.1M | $19.7M | $21.4M | $18.6M | $15.7M | $11.5M | $9.8M | $10.0M | $8.7M | $14.3M |
| Goodwill | $19.9M | $24.2M | $24.2M | $24.2M | $24.2M | $31.2M | $31.2M | $31.2M | $31.2M | $31.2M |
| Intangible assets | $50.2M | $57.3M | $51.9M | $47.7M | $47.1M | $50.1M | $44.8M | $40.5M | $37.8M | $34.6M |
| Total assets | $191M | $211M | $214M | $225M | $205M | $250M | $259M | $246M | $262M | $243M |
| Total liabilities | $97.2M | $126M | $133M | $143M | $146M | $170M | $176M | $167M | $178M | $176M |
| Shareholders' equity | $93.7M | $85.1M | $80.5M | $82.0M | $59.5M | $79.9M | $82.8M | $78.7M | $83.1M | $66.9M |
| Margins | ||||||||||
| Gross margin | 67.6% | 66.2% | 70.7% | 70.7% | 73.3% | 77.1% | 76.8% | 76.1% | 77.0% | 76.2% |
| Operating margin | 6.9% | β4.8% | β1.6% | 1.2% | 1.5% | 3.6% | 9.0% | 9.4% | 11.5% | 2.1% |
| EBITDA margin | 10.4% | β0.8% | 3.4% | 6.2% | 7.2% | 6.4% | 10.9% | 10.9% | 12.9% | 3.7% |
| Net margin | 3.5% | β3.9% | β2.8% | β0.5% | β4.8% | 6.1% | 7.0% | 6.3% | 8.1% | 1.1% |
| FCF margin | 14.3% | 5.5% | 4.9% | 11.7% | 11.8% | 19.9% | 18.7% | 11.1% | 19.7% | 7.8% |
| Returns | ||||||||||
| Return on capital | 10.6% | β9.0% | β3.7% | β | β | 15.8% | β | β | β | β |
| Return on capital employed | 10.1% | β6.8% | β2.8% | 2.2% | 3.0% | 7.2% | 22.5% | 28.0% | 33.3% | 6.7% |
| Return on equity | 7.5% | β8.0% | β7.1% | β1.3% | β13.3% | 19.6% | 22.7% | 22.0% | 28.9% | 4.1% |
| Return on assets | 3.7% | β3.6% | β2.8% | β0.5% | β4.4% | 6.0% | 7.2% | 7.0% | 9.2% | 1.2% |
| Return on tangible equity | 29.7% | β202.0% | β135.5% | β10.1% | β | β | 272.6% | 256.8% | 165.4% | 269.1% |
| Growth | ||||||||||
| Revenue growth | β | β7.4% | 13.2% | 7.4% | β11.9% | 13.0% | 17.3% | 6.7% | 2.4% | β7.0% |
| Net income growth | β | β202.2% | β | β | β | β | 35.3% | β3.5% | 31.6% | β86.9% |
| EPS growth | β | β210.6% | β | β | β | β | 32.3% | β2.4% | 40.3% | β86.2% |
| FCF growth | β | β64.5% | 1.6% | 154.5% | β11.1% | 90.7% | 10.1% | β36.4% | 81.2% | β63.4% |
| Share count change | β | β8.3% | 0.2% | 0.7% | β0.4% | 1.8% | 2.9% | β1.8% | β5.8% | β3.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.4x | β | β1.1x | β | β | β1.1x | β | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | β | β | 0.2x | β | β | β | β |
| Interest coverage | 6.1x | β3.7x | β1.3x | 1.1x | 1.3x | 3.9x | 14.1x | 16.7x | 29.5x | 10.1x |
| Current ratio | 1.7x | 1.1x | 1.1x | 1.2x | 1.0x | 1.0x | 1.0x | 1.0x | 1.0x | 0.8x |
| Quick ratio | 1.6x | 1.1x | 1.0x | 1.1x | 1.0x | 1.0x | 1.0x | 0.9x | 1.0x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.0% | 3.9% | 3.1% | 1.8% | 2.1% | 0.7% | 1.2% | 1.6% | 1.3% | 3.1% |
| Stock comp / revenue | 1.6% | 2.0% | 1.4% | 2.1% | β0.3% | 3.8% | 3.2% | 4.5% | 3.5% | 2.2% |
| Payouts / FCF | 152.0% | 53.4% | 19.4% | 0.0% | 59.8% | 6.7% | 48.6% | 113.9% | 54.4% | 127.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 5.0 | 5.0 | 4.0 | 6.0 | 6.0 | 6.0 | 7.0 | 5.0 |
| Altman Z'' | 4.0 | 1.9 | 1.7 | 2.0 | 1.3 | 1.5 | 2.2 | 2.4 | 2.8 | 1.5 |
| Accruals ratio | β13.4% | β12.2% | β10.7% | β14.3% | β17.2% | β14.3% | β13.3% | β7.1% | β14.5% | β10.3% |
Source: SEC EDGAR XBRL filings (CIK 0000886206). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.